Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 28,011,571
- Total 13F value
- $622,110,124
- Share change
- +1,829,224
- Put/Call ratio
- 37%
- SEC-reported price per share
- $22.21
- Number of holders
- 97
- Value change
- +$47,681,640
- Number of buys
- 54
- Number of sells
- 49
- Shares outstanding
- 51,571,939
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
97
Top holders
10
FDMT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 35104E100
Recent filing periods:
Ownership snapshot
Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 7.8%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 7.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
7.8%
VIKING GLOBAL INVESTORS LP
7.6%
Deep Track Capital, LP
6.2%
BlackRock Finance, Inc.
4.3%
MORGAN STANLEY
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
7.8%
|
$32,220,000
4,007,413 shares
|
— | 30 Sep 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
7.6%
|
$31,661,000
3,937,914 shares
|
— | 30 Sep 2022 |
| Deep Track Capital, LP |
13F
Company
|
6.2%
|
$25,701,000
3,196,642 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.3%
|
$17,933,000
2,230,399 shares
|
— | 30 Sep 2022 |
| MORGAN STANLEY |
13F
Company
|
3.9%
|
$16,252,000
2,021,573 shares
|
— | 30 Sep 2022 |
| ArrowMark Colorado Holdings LLC |
13F
Company
|
3%
|
$12,301,000
1,529,958 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
97
Shares
28,011,571
Rows available
97
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
84
Q4 2022 holders
97
Holder diff
13
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend